22 Nov 2019
CEO confident as Mereo BioPharma moves forward with pivotal Setrusumab study
View on YouTube
11 Nov 2019
Setrusumab: Dose-Dependent Bone Building & Trend in Fracture Reduction
View press release Download PDF (69KB)
07 Oct 2019
FDA Fast Track Designation for Navicixizumab
View Press Release Download PDF (43KB)
17 Sep 2019
Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate Update
View press release Download PDF (766KB)
17 Sep 2019
Mereo Biopharma 2019 Interim Results Conference Call
View press release Download PDF (684KB) View the Webcast

Corporate Presentation

View our latest Corporate Presentation

CORPORATE PRESENTATION

Our Mission

Our mission is to provide new therapies to patients with life limiting oncology and rare diseases that have few, if any, other treatment options.

View more about us